CAS 1262618-39-2: GS967
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | 1,2,4-Triazolo[4,3-a]pyridine, 6-[4-(trifluoromethoxy)phenyl]-3-(trifluoromethyl)- REF: IN-DA000SFDCAS: 1262618-39-2 | 98% | 75,00 €~220,00 € | Lun 03 Mar 25 |
 | GS967 REF: TM-T2049CAS: 1262618-39-2 | 100% - 99.62% | 35,00 €~1.111,00 € | Lun 10 Mar 25 |
 | GS 967 REF: 3D-FT65033CAS: 1262618-39-2 | Min. 95% | 278,00 €~776,00 € | Ven 14 Mar 25 |
![1,2,4-Triazolo[4,3-a]pyridine, 6-[4-(trifluoromethoxy)phenyl]-3-(trifluoromethyl)-](https://static.cymitquimica.com/products/IN/thumb/DA000SFD.jpg)
1,2,4-Triazolo[4,3-a]pyridine, 6-[4-(trifluoromethoxy)phenyl]-3-(trifluoromethyl)-
CAS:1262618-39-2
Formula:
C14H7F6N3O
Purezza:
98%
Colore e forma:
Solid
Peso molecolare:
347.2153
Ref: IN-DA000SFD
| 10mg | 75,00 € | ||
| 25mg | 117,00 € | ||
| 50mg | 198,00 € | ||
| 100mg | 220,00 € |
Consegna stimata in Stati Uniti, il Lunedì 03 Marzo 2025
GS967
CAS:1262618-39-2
GS967 is a potent, and selective inhibitor of cardiac late sodium current (late INa ).
Formula:
C14H7F6N3O
Purezza:
100% - 99.62%
Colore e forma:
Solid
Peso molecolare:
347.22
Ref: TM-T2049
| 2mg | 35,00 € | ||
| 5mg | 52,00 € | ||
| 10mg | 79,00 € | ||
| 25mg | 159,00 € | ||
| 50mg | 284,00 € | ||
| 100mg | 495,00 € | ||
| 200mg | 718,00 € | ||
| 500mg | 1.111,00 € | ||
| 1mL*10mM (DMSO) | 58,00 € |
Consegna stimata in Stati Uniti, il Lunedì 10 Marzo 2025
GS 967
CAS:1262618-39-2
Inhibits cardiac late sodium channel current; antiarrhythmic
Formula:
C14H7F6N3O
Purezza:
Min. 95%
Colore e forma:
Powder
Peso molecolare:
347.22 g/mol
Ref: 3D-FT65033
| 10mg | 278,00 € | ||
| 50mg | 776,00 € |
Consegna stimata in Stati Uniti, il Venerdì 14 Marzo 2025
